newsfilter
← Latest News
ACCESS Newswire·

Moderna Science Day Highlights Expanding Potential of mRNA Platform

Provides broad overview of Company's research and early development programs expected to continue to fuel future growthHighlights validation of T-cell engager modality with mRNA-2808 in multiple myeloma, supporting